GSK is paying docs again — and patients are the worse off

GSK is paying docs again — and patients are the worse off

One of the world’s largest drug makers is paying docs again — and patients are the worse off

By ED SILVERMAN

SANG TAN/AP

One of the world's lagest drug makers, GSK promised it would no longer pay doctors to promote its medicines. Now it says doing so put it at a disadvantage.

READ MORE